The ViroPredict 1.0 predicts the possibility of benefit from VG161 of an HCC patient who received OV by incorporating the input of five independent risk genes(i.e. SEZ6, AKR1C1, LILRA5, NCKAP5, and SETD9). The platform utilizes the expression of input values to calculate the score of each risk factor gene, as well as a total score (i.e. sum of the gene score), which is negatively correlated with the benefit that will be received from the OV treatment.
Declaration: 1. The prediction model only has been designed for application of VG161. 2. The prediction results are for reference only.